<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33051552</PMID><DateCompleted><Year>2021</Year><Month>01</Month><Day>12</Day></DateCompleted><DateRevised><Year>2021</Year><Month>08</Month><Day>03</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>10</Volume><Issue>1</Issue><PubDate><Year>2020</Year><Month>Oct</Month><Day>13</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Therapeutic benefit of Muse cells in a mouse model of amyotrophic lateral sclerosis.</ArticleTitle><Pagination><StartPage>17102</StartPage><MedlinePgn>17102</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">17102</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-020-74216-4</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterized by progressive motor neuron loss. Muse cells are endogenous reparative pluripotent-like stem cells distributed in various tissues. They can selectively home to damaged sites after intravenous injection by sensing sphingosine-1-phosphate produced by damaged cells, then exert pleiotropic effects, including tissue protection and spontaneous differentiation into tissue-constituent cells. In G93A-transgenic ALS mice, intravenous injection of 5.0&#x2009;&#xd7;&#x2009;10<sup>4</sup> cells revealed successful homing of human-Muse cells to the lumbar spinal cords, mainly at the pia-mater and underneath white matter, and exhibited glia-like morphology and GFAP expression. In contrast, such homing or differentiation were not recognized in human mesenchymal stem cells but were instead distributed mainly in the lung. Relative to the vehicle groups, the Muse group significantly improved scores in the rotarod, hanging-wire and muscle strength of lower limbs, recovered the number of motor neurons, and alleviated denervation and myofiber atrophy in lower limb muscles. These results suggest that Muse cells homed in a lesion site-dependent manner and protected the spinal cord against motor neuron death. Muse cells might also be a promising cell source for the treatment of ALS patients.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yamashita</LastName><ForeName>Toru</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Neurology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kushida</LastName><ForeName>Yoshihiro</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Stem Cell Biology and Histology, Tohoku University Graduate School of Medicine, Sendai, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wakao</LastName><ForeName>Shohei</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Stem Cell Biology and Histology, Tohoku University Graduate School of Medicine, Sendai, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tadokoro</LastName><ForeName>Koh</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Neurology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nomura</LastName><ForeName>Emi</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Neurology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Omote</LastName><ForeName>Yoshio</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Neurology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Takemoto</LastName><ForeName>Mami</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hishikawa</LastName><ForeName>Nozomi</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Neurology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ohta</LastName><ForeName>Yasuyuki</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Neurology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dezawa</LastName><ForeName>Mari</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Stem Cell Biology and Histology, Tohoku University Graduate School of Medicine, Sendai, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abe</LastName><ForeName>Koji</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Neurology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan. tooy@d1.dion.ne.jp.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>10</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="ErratumIn"><RefSource>Sci Rep. 2021 Jun 14;11(1):12828</RefSource><PMID Version="1">34127745</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053580" MajorTopicYN="N">Muscle Strength</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D039904" MajorTopicYN="Y">Pluripotent Stem Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D045442" MajorTopicYN="N">Rotarod Performance Test</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D033581" MajorTopicYN="Y">Stem Cell Transplantation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>T. Yamashita, K. Tadokoro, E. Nomura, Y. Ohta, and K. Abe are affiliated with Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences (Okayama, Japan) and Y. Kushida, S. Wakao, and M. Dezawa are affiliated with the Department of Stem Cell Biology and Histology at Tohoku University Graduate School of Medicine (Sendai, Japan), which are parties to a co-development agreement with Life Science Institute, Inc. (LSII; Tokyo, Japan). S. Wakao and M. Dezawa have a patent for Muse cells, and the isolation method thereof licensed to LSII. The other authors report no relevant conflicts.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>8</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>9</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>10</Month><Day>14</Day><Hour>9</Hour><Minute>15</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>10</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>1</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33051552</ArticleId><ArticleId IdType="pmc">PMC7554047</ArticleId><ArticleId IdType="doi">10.1038/s41598-020-74216-4</ArticleId><ArticleId IdType="pii">10.1038/s41598-020-74216-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Aoki M, et al. Mild ALS in Japan associated with novel SOD mutation. Nat. Genet. 1993;5:323&#x2013;324. doi: 10.1038/ng1293-323.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng1293-323</ArticleId><ArticleId IdType="pubmed">8298637</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurney ME, et al. Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation. Science. 1994;264:1772&#x2013;1775. doi: 10.1126/science.8209258.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.8209258</ArticleId><ArticleId IdType="pubmed">8209258</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen DR, et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 1993;362:59&#x2013;62. doi: 10.1038/362059a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/362059a0</ArticleId><ArticleId IdType="pubmed">8446170</ArticleId></ArticleIdList></Reference><Reference><Citation>Arai T, et al. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem. Biophys. Res. Commun. 2006;351:602&#x2013;611. doi: 10.1016/j.bbrc.2006.10.093.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2006.10.093</ArticleId><ArticleId IdType="pubmed">17084815</ArticleId></ArticleIdList></Reference><Reference><Citation>Kabashi E, et al. TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis. Nat. Genet. 2008;40:572&#x2013;574. doi: 10.1038/ng.132.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.132</ArticleId><ArticleId IdType="pubmed">18372902</ArticleId></ArticleIdList></Reference><Reference><Citation>DeJesus-Hernandez M, et al. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron. 2011;72:245&#x2013;256. doi: 10.1016/j.neuron.2011.09.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.09.011</ArticleId><ArticleId IdType="pmc">PMC3202986</ArticleId><ArticleId IdType="pubmed">21944778</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton AE, et al. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron. 2011;72:257&#x2013;268. doi: 10.1016/j.neuron.2011.09.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.09.010</ArticleId><ArticleId IdType="pmc">PMC3200438</ArticleId><ArticleId IdType="pubmed">21944779</ArticleId></ArticleIdList></Reference><Reference><Citation>Abe K, et al. Exploratory double-blind, parallel-group, placebo-controlled study of edaravone (MCI-186) in amyotrophic lateral sclerosis (Japan ALS severity classification: Grade 3, requiring assistance for eating, excretion or ambulation) Amyotroph. Lateral Scler. Front. 2017;18:40&#x2013;48. doi: 10.1080/21678421.2017.1361441.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2017.1361441</ArticleId><ArticleId IdType="pubmed">28872915</ArticleId></ArticleIdList></Reference><Reference><Citation>Writing G, Edaravone ALSSG. Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: A randomised, double-blind, placebo-controlled trial. Lancet Neurol. 2017;16:505&#x2013;512. doi: 10.1016/S1474-4422(17)30115-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(17)30115-1</ArticleId><ArticleId IdType="pubmed">28522181</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuroda Y, et al. Unique multipotent cells in adult human mesenchymal cell populations. Proc. Natl. Acad. Sci. USA. 2010;107:8639&#x2013;8643. doi: 10.1073/pnas.0911647107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0911647107</ArticleId><ArticleId IdType="pmc">PMC2889306</ArticleId><ArticleId IdType="pubmed">20421459</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuroda Y, et al. Isolation, culture and evaluation of multilineage-differentiating stress-enduring (Muse) cells. Nat. Protoc. 2013;8:1391&#x2013;1415. doi: 10.1038/nprot.2013.076.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nprot.2013.076</ArticleId><ArticleId IdType="pubmed">23787896</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanaka T, et al. Mobilized Muse cells after acute myocardial infarction predict cardiac function and remodeling in the chronic phase. Circ. J. 2018;82:561&#x2013;571. doi: 10.1253/circj.CJ-17-0552.</Citation><ArticleIdList><ArticleId IdType="doi">10.1253/circj.CJ-17-0552</ArticleId><ArticleId IdType="pubmed">28931784</ArticleId></ArticleIdList></Reference><Reference><Citation>Wakao S, et al. Multilineage-differentiating stress-enduring (Muse) cells are a primary source of induced pluripotent stem cells in human fibroblasts. Proc. Natl. Acad. Sci. USA. 2011;108:9875&#x2013;9880. doi: 10.1073/pnas.1100816108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1100816108</ArticleId><ArticleId IdType="pmc">PMC3116385</ArticleId><ArticleId IdType="pubmed">21628574</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujita Y, et al. Intravenous injection of Muse cells as a potential therapeutic approach for epidermolysis bullosa. J. Invest. Dermatol. 2020 doi: 10.1016/j.jid.2020.05.092.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jid.2020.05.092</ArticleId><ArticleId IdType="pubmed">32540249</ArticleId></ArticleIdList></Reference><Reference><Citation>Iseki M, et al. Muse cells, nontumorigenic pluripotent-like stem cells, have liver regeneration capacity through specific homing and cell replacement in a mouse model of liver fibrosis. Cell Transpl. 2017;26:821&#x2013;840. doi: 10.3727/096368916X693662.</Citation><ArticleIdList><ArticleId IdType="doi">10.3727/096368916X693662</ArticleId><ArticleId IdType="pmc">PMC5657714</ArticleId><ArticleId IdType="pubmed">27938474</ArticleId></ArticleIdList></Reference><Reference><Citation>Uchida H, et al. Human Muse cells reconstruct neuronal circuitry in subacute lacunar stroke model. Stroke. 2017;48:428&#x2013;435. doi: 10.1161/STROKEAHA.116.014950.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.116.014950</ArticleId><ArticleId IdType="pmc">PMC5262965</ArticleId><ArticleId IdType="pubmed">27999136</ArticleId></ArticleIdList></Reference><Reference><Citation>Uchida N, et al. Beneficial effects of systemically administered human Muse cells in adriamycin nephropathy. J. Am. Soc. Nephrol. 2017;28:2946&#x2013;2960. doi: 10.1681/ASN.2016070775.</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2016070775</ArticleId><ArticleId IdType="pmc">PMC5619953</ArticleId><ArticleId IdType="pubmed">28674043</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamada Y, et al. S1P&#x2013;S1PR2 Axis mediates homing of Muse cells into damaged heart for long-lasting tissue repair and functional recovery after acute myocardial infarction. Circ. Res. 2018;122:1069&#x2013;1083. doi: 10.1161/CIRCRESAHA.117.311648.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.117.311648</ArticleId><ArticleId IdType="pubmed">29475983</ArticleId></ArticleIdList></Reference><Reference><Citation>Yabuki H, Wakao S, Kushida Y, Dezawa M, Okada Y. Human multilineage-differentiating stress-enduring cells exert pleiotropic effects to ameliorate acute lung ischemia-reperfusion injury in a rat model. Cell Transpl. 2018;27:979&#x2013;993. doi: 10.1177/0963689718761657.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0963689718761657</ArticleId><ArticleId IdType="pmc">PMC6050908</ArticleId><ArticleId IdType="pubmed">29707971</ArticleId></ArticleIdList></Reference><Reference><Citation>Dezawa M. Clinical trials of Muse cells. Adv. Exp. Med. Biol. 2018;1103:305&#x2013;307. doi: 10.1007/978-4-431-56847-6_17.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-4-431-56847-6_17</ArticleId><ArticleId IdType="pubmed">30484237</ArticleId></ArticleIdList></Reference><Reference><Citation>Noda T, Nishigaki K, Minatoguchi S. Safety and efficacy of human Muse cell-based product for acute myocardial infarction in a first-in-human trial. Circ. J. 2020 doi: 10.1253/circj.CJ-20-0307.</Citation><ArticleIdList><ArticleId IdType="doi">10.1253/circj.CJ-20-0307</ArticleId><ArticleId IdType="pubmed">32522904</ArticleId></ArticleIdList></Reference><Reference><Citation>Forostyak S, Jendelova P, Kapcalova M, Arboleda D, Sykova E. Mesenchymal stromal cells prolong the lifespan in a rat model of amyotrophic lateral sclerosis. Cytotherapy. 2011;13:1036&#x2013;1046. doi: 10.3109/14653249.2011.592521.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/14653249.2011.592521</ArticleId><ArticleId IdType="pubmed">21736505</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim H, et al. Dose-dependent efficacy of ALS-human mesenchymal stem cells transplantation into cisterna magna in SOD1-G93A ALS mice. Neurosci. Lett. 2010;468:190&#x2013;194. doi: 10.1016/j.neulet.2009.10.074.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2009.10.074</ArticleId><ArticleId IdType="pubmed">19879334</ArticleId></ArticleIdList></Reference><Reference><Citation>Abe T, et al. Intravenously transplanted human multilineage-differentiating stress-enduring cells afford brain repair in a mouse lacunar stroke model. Stroke. 2020;51:601&#x2013;611. doi: 10.1161/STROKEAHA.119.026589.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.119.026589</ArticleId><ArticleId IdType="pubmed">31826733</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohta Y, et al. Neuroprotective and angiogenic effects of bone marrow transplantation combined with granulocyte colony-stimulating factor in a mouse model of amyotrophic lateral sclerosis. Cell Med. 2011;2:69&#x2013;83. doi: 10.3727/215517910X582779.</Citation><ArticleIdList><ArticleId IdType="doi">10.3727/215517910X582779</ArticleId><ArticleId IdType="pmc">PMC4789328</ArticleId><ArticleId IdType="pubmed">26998403</ArticleId></ArticleIdList></Reference><Reference><Citation>Bossolasco P, et al. Metalloproteinase alterations in the bone marrow of ALS patients. J. Mol. Med. (Berl.) 2010;88:553&#x2013;564. doi: 10.1007/s00109-009-0584-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00109-009-0584-7</ArticleId><ArticleId IdType="pubmed">20091292</ArticleId></ArticleIdList></Reference><Reference><Citation>Kondo T, et al. Focal transplantation of human iPSC-derived glial-rich neural progenitors improves lifespan of ALS mice. Stem Cell Reports. 2014;3:242&#x2013;249. doi: 10.1016/j.stemcr.2014.05.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2014.05.017</ArticleId><ArticleId IdType="pmc">PMC4175543</ArticleId><ArticleId IdType="pubmed">25254338</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyazaki K, et al. Disruption of neurovascular unit prior to motor neuron degeneration in amyotrophic lateral sclerosis. J. Neurosci. Res. 2011;89:718&#x2013;728. doi: 10.1002/jnr.22594.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jnr.22594</ArticleId><ArticleId IdType="pubmed">21337372</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamanaka K, et al. Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis. Nat. Neurosci. 2008;11:251&#x2013;253. doi: 10.1038/nn2047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn2047</ArticleId><ArticleId IdType="pmc">PMC3137510</ArticleId><ArticleId IdType="pubmed">18246065</ArticleId></ArticleIdList></Reference><Reference><Citation>Liddelow SA, et al. Neurotoxic reactive astrocytes are induced by activated microglia. Nature. 2017;541:481&#x2013;487. doi: 10.1038/nature21029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature21029</ArticleId><ArticleId IdType="pmc">PMC5404890</ArticleId><ArticleId IdType="pubmed">28099414</ArticleId></ArticleIdList></Reference><Reference><Citation>Nitobe Y, et al. Neurotrophic factor secretion and neural differentiation potential of multilineage-differentiating stress-enduring (Muse) cells derived from mouse adipose tissue. Cell Transpl. 2019;28:1132&#x2013;1139. doi: 10.1177/0963689719863809.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0963689719863809</ArticleId><ArticleId IdType="pmc">PMC6767880</ArticleId><ArticleId IdType="pubmed">31304790</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayase M, et al. Committed neural progenitor cells derived from genetically modified bone marrow stromal cells ameliorate deficits in a rat model of stroke. J. Cereb. Blood Flow Metab. 2009;29:1409&#x2013;1420. doi: 10.1038/jcbfm.2009.62.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/jcbfm.2009.62</ArticleId><ArticleId IdType="pubmed">19436312</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y, Imai H, Ito A, Saito N. Novel modified method for injection into the cerebrospinal fluid via the cerebellomedullary cistern in mice. Acta Neurobiol. Exp. (Wars) 2013;73:304&#x2013;311.</Citation><ArticleIdList><ArticleId IdType="pubmed">23823990</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohta Y, et al. Therapeutic benefits of intrathecal protein therapy in a mouse model of amyotrophic lateral sclerosis. J. Neurosci. Res. 2008;86:3028&#x2013;3037. doi: 10.1002/jnr.21747.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jnr.21747</ArticleId><ArticleId IdType="pubmed">18543336</ArticleId></ArticleIdList></Reference><Reference><Citation>Saito K, et al. Luminescent proteins for high-speed single-cell and whole-body imaging. Nat. Commun. 2012;3:1262. doi: 10.1038/ncomms2248.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms2248</ArticleId><ArticleId IdType="pmc">PMC3535334</ArticleId><ArticleId IdType="pubmed">23232392</ArticleId></ArticleIdList></Reference><Reference><Citation>Vinsant S, et al. Characterization of early pathogenesis in the SOD1(G93A) mouse model of ALS: Part I, background and methods. Brain Behav. 2013;3:335&#x2013;350. doi: 10.1002/brb3.143.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/brb3.143</ArticleId><ArticleId IdType="pmc">PMC3869677</ArticleId><ArticleId IdType="pubmed">24381807</ArticleId></ArticleIdList></Reference><Reference><Citation>Abe K, Morita S, Kikuchi T, Itoyama Y. Protective effect of a novel free radical scavenger, OPC-14117, on wobbler mouse motor neuron disease. J. Neurosci. Res. 1997;48:63&#x2013;70. doi: 10.1002/(SICI)1097-4547(19970401)48:1&lt;63::AID-JNR6&gt;3.0.CO;2-C.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/(SICI)1097-4547(19970401)48:1&lt;63::AID-JNR6&gt;3.0.CO;2-C</ArticleId><ArticleId IdType="pubmed">9086182</ArticleId></ArticleIdList></Reference><Reference><Citation>Hosaka Y, et al. Alpha1-syntrophin-deficient skeletal muscle exhibits hypertrophy and aberrant formation of neuromuscular junctions during regeneration. J. Cell Biol. 2002;158:1097&#x2013;1107. doi: 10.1083/jcb.200204076.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.200204076</ArticleId><ArticleId IdType="pmc">PMC2173222</ArticleId><ArticleId IdType="pubmed">12221071</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagano I, et al. Therapeutic benefit of intrathecal injection of insulin-like growth factor-1 in a mouse model of amyotrophic lateral sclerosis. J. Neurol. Sci. 2005;235:61&#x2013;68. doi: 10.1016/j.jns.2005.04.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2005.04.011</ArticleId><ArticleId IdType="pubmed">15990113</ArticleId></ArticleIdList></Reference><Reference><Citation>Manabe Y, et al. Glial cell line-derived neurotrophic factor protein prevents motor neuron loss of transgenic model mice for amyotrophic lateral sclerosis. Neurol. Res. 2003;25:195&#x2013;200. doi: 10.1179/016164103101201193.</Citation><ArticleIdList><ArticleId IdType="doi">10.1179/016164103101201193</ArticleId><ArticleId IdType="pubmed">12635522</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>